Picture of Horizon Therapeutics logo

HZNP — Horizon Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge Cap

US FTC suspends challenge to Amgen's deal for Horizon Therapeutics

Aug 26 (Reuters) - The U.S. Federal Trade Commission
(FTC) has suspended its challenge of Amgen's  AMGN.O  $27.8
billion purchase of Horizon Therapeutics  HZNP.O , a filing late
on Friday showed. 

 (Reporting by Urvi Dugar in Bengaluru; editing by Jason Neely)
 ((UrviManoj.Dugar@thomsonreuters.com;))

Recent news on Horizon Therapeutics

See all news